Open AccessEffects of SGLT2 inhibitors on cardiovascular and renal outcomes in type 2 diabetes
Author(s) -
Mei Qiu,
Liang-Liang Ding,
Hai-Rong Zhou
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000025121
Subject(s) - medicine , mace , myocardial infarction , stroke (engine) , heart failure , type 2 diabetes , hazard ratio , randomized controlled trial , diabetes mellitus , renal function , clinical endpoint , canagliflozin , cardiology , confidence interval , percutaneous coronary intervention , endocrinology , mechanical engineering , engineering